Global Vaccine for Influenza Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Vaccine for Influenza Market Size was estimated at USD 5690.45 million in 2023 and is projected to reach USD 7846.24 million by 2029, exhibiting a CAGR of 5.50% during the forecast period.
This report provides a deep insight into the global Vaccine for Influenza market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine for Influenza Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine for Influenza market in any manner.
Global Vaccine for Influenza Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
6 Months to 3 Years
> 3 Years
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine for Influenza Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Vaccine for Influenza Market Size was estimated at USD 5690.45 million in 2023 and is projected to reach USD 7846.24 million by 2029, exhibiting a CAGR of 5.50% during the forecast period.
This report provides a deep insight into the global Vaccine for Influenza market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine for Influenza Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine for Influenza market in any manner.
Global Vaccine for Influenza Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
6 Months to 3 Years
> 3 Years
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Vaccine for Influenza Market
- Overview of the regional outlook of the Vaccine for Influenza Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine for Influenza Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Vaccine for Influenza
1.2 Key Market Segments
1.2.1 Vaccine for Influenza Segment by Type
1.2.2 Vaccine for Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCINE FOR INFLUENZA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccine for Influenza Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Vaccine for Influenza Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VACCINE FOR INFLUENZA MARKET COMPETITIVE LANDSCAPE
3.1 Global Vaccine for Influenza Sales by Manufacturers (2019-2024)
3.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaccine for Influenza Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaccine for Influenza Sales Sites, Area Served, Product Type
3.6 Vaccine for Influenza Market Competitive Situation and Trends
3.6.1 Vaccine for Influenza Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaccine for Influenza Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VACCINE FOR INFLUENZA INDUSTRY CHAIN ANALYSIS
4.1 Vaccine for Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCINE FOR INFLUENZA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VACCINE FOR INFLUENZA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine for Influenza Sales Market Share by Type (2019-2024)
6.3 Global Vaccine for Influenza Market Size Market Share by Type (2019-2024)
6.4 Global Vaccine for Influenza Price by Type (2019-2024)
7 VACCINE FOR INFLUENZA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine for Influenza Market Sales by Application (2019-2024)
7.3 Global Vaccine for Influenza Market Size (M USD) by Application (2019-2024)
7.4 Global Vaccine for Influenza Sales Growth Rate by Application (2019-2024)
8 VACCINE FOR INFLUENZA MARKET SEGMENTATION BY REGION
8.1 Global Vaccine for Influenza Sales by Region
8.1.1 Global Vaccine for Influenza Sales by Region
8.1.2 Global Vaccine for Influenza Sales Market Share by Region
8.2 North America
8.2.1 North America Vaccine for Influenza Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vaccine for Influenza Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vaccine for Influenza Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vaccine for Influenza Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vaccine for Influenza Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi
9.1.1 Sanofi Vaccine for Influenza Basic Information
9.1.2 Sanofi Vaccine for Influenza Product Overview
9.1.3 Sanofi Vaccine for Influenza Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Vaccine for Influenza SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 CSL
9.2.1 CSL Vaccine for Influenza Basic Information
9.2.2 CSL Vaccine for Influenza Product Overview
9.2.3 CSL Vaccine for Influenza Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Vaccine for Influenza SWOT Analysis
9.2.6 CSL Recent Developments
9.3 GSK
9.3.1 GSK Vaccine for Influenza Basic Information
9.3.2 GSK Vaccine for Influenza Product Overview
9.3.3 GSK Vaccine for Influenza Product Market Performance
9.3.4 GSK Vaccine for Influenza SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Viatris
9.4.1 Viatris Vaccine for Influenza Basic Information
9.4.2 Viatris Vaccine for Influenza Product Overview
9.4.3 Viatris Vaccine for Influenza Product Market Performance
9.4.4 Viatris Business Overview
9.4.5 Viatris Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Vaccine for Influenza Basic Information
9.5.2 AstraZeneca Vaccine for Influenza Product Overview
9.5.3 AstraZeneca Vaccine for Influenza Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Hualan Bio
9.6.1 Hualan Bio Vaccine for Influenza Basic Information
9.6.2 Hualan Bio Vaccine for Influenza Product Overview
9.6.3 Hualan Bio Vaccine for Influenza Product Market Performance
9.6.4 Hualan Bio Business Overview
9.6.5 Hualan Bio Recent Developments
9.7 Changchun Institute of Biological
9.7.1 Changchun Institute of Biological Vaccine for Influenza Basic Information
9.7.2 Changchun Institute of Biological Vaccine for Influenza Product Overview
9.7.3 Changchun Institute of Biological Vaccine for Influenza Product Market Performance
9.7.4 Changchun Institute of Biological Business Overview
9.7.5 Changchun Institute of Biological Recent Developments
9.8 Sinovac
9.8.1 Sinovac Vaccine for Influenza Basic Information
9.8.2 Sinovac Vaccine for Influenza Product Overview
9.8.3 Sinovac Vaccine for Influenza Product Market Performance
9.8.4 Sinovac Business Overview
9.8.5 Sinovac Recent Developments
9.9 BCHT
9.9.1 BCHT Vaccine for Influenza Basic Information
9.9.2 BCHT Vaccine for Influenza Product Overview
9.9.3 BCHT Vaccine for Influenza Product Market Performance
9.9.4 BCHT Business Overview
9.9.5 BCHT Recent Developments
9.10 Jiangsu GDK
9.10.1 Jiangsu GDK Vaccine for Influenza Basic Information
9.10.2 Jiangsu GDK Vaccine for Influenza Product Overview
9.10.3 Jiangsu GDK Vaccine for Influenza Product Market Performance
9.10.4 Jiangsu GDK Business Overview
9.10.5 Jiangsu GDK Recent Developments
9.11 KM Biologics
9.11.1 KM Biologics Vaccine for Influenza Basic Information
9.11.2 KM Biologics Vaccine for Influenza Product Overview
9.11.3 KM Biologics Vaccine for Influenza Product Market Performance
9.11.4 KM Biologics Business Overview
9.11.5 KM Biologics Recent Developments
10 VACCINE FOR INFLUENZA MARKET FORECAST BY REGION
10.1 Global Vaccine for Influenza Market Size Forecast
10.2 Global Vaccine for Influenza Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Vaccine for Influenza Market Size Forecast by Country
10.2.3 Asia Pacific Vaccine for Influenza Market Size Forecast by Region
10.2.4 South America Vaccine for Influenza Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Vaccine for Influenza by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Vaccine for Influenza Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2025-2030)
11.1.2 Global Vaccine for Influenza Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Vaccine for Influenza by Type (2025-2030)
11.2 Global Vaccine for Influenza Market Forecast by Application (2025-2030)
11.2.1 Global Vaccine for Influenza Sales (Kilotons) Forecast by Application
11.2.2 Global Vaccine for Influenza Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Vaccine for Influenza
1.2 Key Market Segments
1.2.1 Vaccine for Influenza Segment by Type
1.2.2 Vaccine for Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCINE FOR INFLUENZA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccine for Influenza Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Vaccine for Influenza Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VACCINE FOR INFLUENZA MARKET COMPETITIVE LANDSCAPE
3.1 Global Vaccine for Influenza Sales by Manufacturers (2019-2024)
3.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaccine for Influenza Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaccine for Influenza Sales Sites, Area Served, Product Type
3.6 Vaccine for Influenza Market Competitive Situation and Trends
3.6.1 Vaccine for Influenza Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaccine for Influenza Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VACCINE FOR INFLUENZA INDUSTRY CHAIN ANALYSIS
4.1 Vaccine for Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCINE FOR INFLUENZA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VACCINE FOR INFLUENZA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine for Influenza Sales Market Share by Type (2019-2024)
6.3 Global Vaccine for Influenza Market Size Market Share by Type (2019-2024)
6.4 Global Vaccine for Influenza Price by Type (2019-2024)
7 VACCINE FOR INFLUENZA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine for Influenza Market Sales by Application (2019-2024)
7.3 Global Vaccine for Influenza Market Size (M USD) by Application (2019-2024)
7.4 Global Vaccine for Influenza Sales Growth Rate by Application (2019-2024)
8 VACCINE FOR INFLUENZA MARKET SEGMENTATION BY REGION
8.1 Global Vaccine for Influenza Sales by Region
8.1.1 Global Vaccine for Influenza Sales by Region
8.1.2 Global Vaccine for Influenza Sales Market Share by Region
8.2 North America
8.2.1 North America Vaccine for Influenza Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vaccine for Influenza Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vaccine for Influenza Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vaccine for Influenza Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vaccine for Influenza Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi
9.1.1 Sanofi Vaccine for Influenza Basic Information
9.1.2 Sanofi Vaccine for Influenza Product Overview
9.1.3 Sanofi Vaccine for Influenza Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Vaccine for Influenza SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 CSL
9.2.1 CSL Vaccine for Influenza Basic Information
9.2.2 CSL Vaccine for Influenza Product Overview
9.2.3 CSL Vaccine for Influenza Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Vaccine for Influenza SWOT Analysis
9.2.6 CSL Recent Developments
9.3 GSK
9.3.1 GSK Vaccine for Influenza Basic Information
9.3.2 GSK Vaccine for Influenza Product Overview
9.3.3 GSK Vaccine for Influenza Product Market Performance
9.3.4 GSK Vaccine for Influenza SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Viatris
9.4.1 Viatris Vaccine for Influenza Basic Information
9.4.2 Viatris Vaccine for Influenza Product Overview
9.4.3 Viatris Vaccine for Influenza Product Market Performance
9.4.4 Viatris Business Overview
9.4.5 Viatris Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Vaccine for Influenza Basic Information
9.5.2 AstraZeneca Vaccine for Influenza Product Overview
9.5.3 AstraZeneca Vaccine for Influenza Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Hualan Bio
9.6.1 Hualan Bio Vaccine for Influenza Basic Information
9.6.2 Hualan Bio Vaccine for Influenza Product Overview
9.6.3 Hualan Bio Vaccine for Influenza Product Market Performance
9.6.4 Hualan Bio Business Overview
9.6.5 Hualan Bio Recent Developments
9.7 Changchun Institute of Biological
9.7.1 Changchun Institute of Biological Vaccine for Influenza Basic Information
9.7.2 Changchun Institute of Biological Vaccine for Influenza Product Overview
9.7.3 Changchun Institute of Biological Vaccine for Influenza Product Market Performance
9.7.4 Changchun Institute of Biological Business Overview
9.7.5 Changchun Institute of Biological Recent Developments
9.8 Sinovac
9.8.1 Sinovac Vaccine for Influenza Basic Information
9.8.2 Sinovac Vaccine for Influenza Product Overview
9.8.3 Sinovac Vaccine for Influenza Product Market Performance
9.8.4 Sinovac Business Overview
9.8.5 Sinovac Recent Developments
9.9 BCHT
9.9.1 BCHT Vaccine for Influenza Basic Information
9.9.2 BCHT Vaccine for Influenza Product Overview
9.9.3 BCHT Vaccine for Influenza Product Market Performance
9.9.4 BCHT Business Overview
9.9.5 BCHT Recent Developments
9.10 Jiangsu GDK
9.10.1 Jiangsu GDK Vaccine for Influenza Basic Information
9.10.2 Jiangsu GDK Vaccine for Influenza Product Overview
9.10.3 Jiangsu GDK Vaccine for Influenza Product Market Performance
9.10.4 Jiangsu GDK Business Overview
9.10.5 Jiangsu GDK Recent Developments
9.11 KM Biologics
9.11.1 KM Biologics Vaccine for Influenza Basic Information
9.11.2 KM Biologics Vaccine for Influenza Product Overview
9.11.3 KM Biologics Vaccine for Influenza Product Market Performance
9.11.4 KM Biologics Business Overview
9.11.5 KM Biologics Recent Developments
10 VACCINE FOR INFLUENZA MARKET FORECAST BY REGION
10.1 Global Vaccine for Influenza Market Size Forecast
10.2 Global Vaccine for Influenza Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Vaccine for Influenza Market Size Forecast by Country
10.2.3 Asia Pacific Vaccine for Influenza Market Size Forecast by Region
10.2.4 South America Vaccine for Influenza Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Vaccine for Influenza by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Vaccine for Influenza Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2025-2030)
11.1.2 Global Vaccine for Influenza Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Vaccine for Influenza by Type (2025-2030)
11.2 Global Vaccine for Influenza Market Forecast by Application (2025-2030)
11.2.1 Global Vaccine for Influenza Sales (Kilotons) Forecast by Application
11.2.2 Global Vaccine for Influenza Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vaccine for Influenza Market Size Comparison by Region (M USD)
Table 5. Global Vaccine for Influenza Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Vaccine for Influenza Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Vaccine for Influenza Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Vaccine for Influenza Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2022)
Table 10. Global Market Vaccine for Influenza Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Vaccine for Influenza Sales Sites and Area Served
Table 12. Manufacturers Vaccine for Influenza Product Type
Table 13. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Vaccine for Influenza
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaccine for Influenza Market Challenges
Table 22. Global Vaccine for Influenza Sales by Type (Kilotons)
Table 23. Global Vaccine for Influenza Market Size by Type (M USD)
Table 24. Global Vaccine for Influenza Sales (Kilotons) by Type (2019-2024)
Table 25. Global Vaccine for Influenza Sales Market Share by Type (2019-2024)
Table 26. Global Vaccine for Influenza Market Size (M USD) by Type (2019-2024)
Table 27. Global Vaccine for Influenza Market Size Share by Type (2019-2024)
Table 28. Global Vaccine for Influenza Price (USD/Ton) by Type (2019-2024)
Table 29. Global Vaccine for Influenza Sales (Kilotons) by Application
Table 30. Global Vaccine for Influenza Market Size by Application
Table 31. Global Vaccine for Influenza Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Vaccine for Influenza Sales Market Share by Application (2019-2024)
Table 33. Global Vaccine for Influenza Sales by Application (2019-2024) & (M USD)
Table 34. Global Vaccine for Influenza Market Share by Application (2019-2024)
Table 35. Global Vaccine for Influenza Sales Growth Rate by Application (2019-2024)
Table 36. Global Vaccine for Influenza Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Vaccine for Influenza Sales Market Share by Region (2019-2024)
Table 38. North America Vaccine for Influenza Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Vaccine for Influenza Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Vaccine for Influenza Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Vaccine for Influenza Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Vaccine for Influenza Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Vaccine for Influenza Basic Information
Table 44. Sanofi Vaccine for Influenza Product Overview
Table 45. Sanofi Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Vaccine for Influenza SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. CSL Vaccine for Influenza Basic Information
Table 50. CSL Vaccine for Influenza Product Overview
Table 51. CSL Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Vaccine for Influenza SWOT Analysis
Table 54. CSL Recent Developments
Table 55. GSK Vaccine for Influenza Basic Information
Table 56. GSK Vaccine for Influenza Product Overview
Table 57. GSK Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GSK Vaccine for Influenza SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. Viatris Vaccine for Influenza Basic Information
Table 62. Viatris Vaccine for Influenza Product Overview
Table 63. Viatris Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Viatris Business Overview
Table 65. Viatris Recent Developments
Table 66. AstraZeneca Vaccine for Influenza Basic Information
Table 67. AstraZeneca Vaccine for Influenza Product Overview
Table 68. AstraZeneca Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Hualan Bio Vaccine for Influenza Basic Information
Table 72. Hualan Bio Vaccine for Influenza Product Overview
Table 73. Hualan Bio Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hualan Bio Business Overview
Table 75. Hualan Bio Recent Developments
Table 76. Changchun Institute of Biological Vaccine for Influenza Basic Information
Table 77. Changchun Institute of Biological Vaccine for Influenza Product Overview
Table 78. Changchun Institute of Biological Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Changchun Institute of Biological Business Overview
Table 80. Changchun Institute of Biological Recent Developments
Table 81. Sinovac Vaccine for Influenza Basic Information
Table 82. Sinovac Vaccine for Influenza Product Overview
Table 83. Sinovac Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sinovac Business Overview
Table 85. Sinovac Recent Developments
Table 86. BCHT Vaccine for Influenza Basic Information
Table 87. BCHT Vaccine for Influenza Product Overview
Table 88. BCHT Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. BCHT Business Overview
Table 90. BCHT Recent Developments
Table 91. Jiangsu GDK Vaccine for Influenza Basic Information
Table 92. Jiangsu GDK Vaccine for Influenza Product Overview
Table 93. Jiangsu GDK Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu GDK Business Overview
Table 95. Jiangsu GDK Recent Developments
Table 96. KM Biologics Vaccine for Influenza Basic Information
Table 97. KM Biologics Vaccine for Influenza Product Overview
Table 98. KM Biologics Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. KM Biologics Business Overview
Table 100. KM Biologics Recent Developments
Table 101. Global Vaccine for Influenza Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Vaccine for Influenza Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Vaccine for Influenza Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Vaccine for Influenza Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Vaccine for Influenza Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Vaccine for Influenza Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Vaccine for Influenza Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Vaccine for Influenza Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Vaccine for Influenza Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Vaccine for Influenza Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Vaccine for Influenza Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Vaccine for Influenza Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Vaccine for Influenza Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Vaccine for Influenza Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Vaccine for Influenza Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Vaccine for Influenza Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Vaccine for Influenza Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vaccine for Influenza Market Size Comparison by Region (M USD)
Table 5. Global Vaccine for Influenza Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Vaccine for Influenza Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Vaccine for Influenza Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Vaccine for Influenza Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2022)
Table 10. Global Market Vaccine for Influenza Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Vaccine for Influenza Sales Sites and Area Served
Table 12. Manufacturers Vaccine for Influenza Product Type
Table 13. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Vaccine for Influenza
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaccine for Influenza Market Challenges
Table 22. Global Vaccine for Influenza Sales by Type (Kilotons)
Table 23. Global Vaccine for Influenza Market Size by Type (M USD)
Table 24. Global Vaccine for Influenza Sales (Kilotons) by Type (2019-2024)
Table 25. Global Vaccine for Influenza Sales Market Share by Type (2019-2024)
Table 26. Global Vaccine for Influenza Market Size (M USD) by Type (2019-2024)
Table 27. Global Vaccine for Influenza Market Size Share by Type (2019-2024)
Table 28. Global Vaccine for Influenza Price (USD/Ton) by Type (2019-2024)
Table 29. Global Vaccine for Influenza Sales (Kilotons) by Application
Table 30. Global Vaccine for Influenza Market Size by Application
Table 31. Global Vaccine for Influenza Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Vaccine for Influenza Sales Market Share by Application (2019-2024)
Table 33. Global Vaccine for Influenza Sales by Application (2019-2024) & (M USD)
Table 34. Global Vaccine for Influenza Market Share by Application (2019-2024)
Table 35. Global Vaccine for Influenza Sales Growth Rate by Application (2019-2024)
Table 36. Global Vaccine for Influenza Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Vaccine for Influenza Sales Market Share by Region (2019-2024)
Table 38. North America Vaccine for Influenza Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Vaccine for Influenza Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Vaccine for Influenza Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Vaccine for Influenza Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Vaccine for Influenza Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Vaccine for Influenza Basic Information
Table 44. Sanofi Vaccine for Influenza Product Overview
Table 45. Sanofi Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Vaccine for Influenza SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. CSL Vaccine for Influenza Basic Information
Table 50. CSL Vaccine for Influenza Product Overview
Table 51. CSL Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Vaccine for Influenza SWOT Analysis
Table 54. CSL Recent Developments
Table 55. GSK Vaccine for Influenza Basic Information
Table 56. GSK Vaccine for Influenza Product Overview
Table 57. GSK Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GSK Vaccine for Influenza SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. Viatris Vaccine for Influenza Basic Information
Table 62. Viatris Vaccine for Influenza Product Overview
Table 63. Viatris Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Viatris Business Overview
Table 65. Viatris Recent Developments
Table 66. AstraZeneca Vaccine for Influenza Basic Information
Table 67. AstraZeneca Vaccine for Influenza Product Overview
Table 68. AstraZeneca Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Hualan Bio Vaccine for Influenza Basic Information
Table 72. Hualan Bio Vaccine for Influenza Product Overview
Table 73. Hualan Bio Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hualan Bio Business Overview
Table 75. Hualan Bio Recent Developments
Table 76. Changchun Institute of Biological Vaccine for Influenza Basic Information
Table 77. Changchun Institute of Biological Vaccine for Influenza Product Overview
Table 78. Changchun Institute of Biological Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Changchun Institute of Biological Business Overview
Table 80. Changchun Institute of Biological Recent Developments
Table 81. Sinovac Vaccine for Influenza Basic Information
Table 82. Sinovac Vaccine for Influenza Product Overview
Table 83. Sinovac Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sinovac Business Overview
Table 85. Sinovac Recent Developments
Table 86. BCHT Vaccine for Influenza Basic Information
Table 87. BCHT Vaccine for Influenza Product Overview
Table 88. BCHT Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. BCHT Business Overview
Table 90. BCHT Recent Developments
Table 91. Jiangsu GDK Vaccine for Influenza Basic Information
Table 92. Jiangsu GDK Vaccine for Influenza Product Overview
Table 93. Jiangsu GDK Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu GDK Business Overview
Table 95. Jiangsu GDK Recent Developments
Table 96. KM Biologics Vaccine for Influenza Basic Information
Table 97. KM Biologics Vaccine for Influenza Product Overview
Table 98. KM Biologics Vaccine for Influenza Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. KM Biologics Business Overview
Table 100. KM Biologics Recent Developments
Table 101. Global Vaccine for Influenza Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Vaccine for Influenza Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Vaccine for Influenza Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Vaccine for Influenza Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Vaccine for Influenza Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Vaccine for Influenza Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Vaccine for Influenza Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Vaccine for Influenza Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Vaccine for Influenza Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Vaccine for Influenza Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Vaccine for Influenza Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Vaccine for Influenza Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Vaccine for Influenza Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Vaccine for Influenza Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Vaccine for Influenza Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Vaccine for Influenza Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Vaccine for Influenza Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Vaccine for Influenza
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccine for Influenza Market Size (M USD), 2019-2030
Figure 5. Global Vaccine for Influenza Market Size (M USD) (2019-2030)
Figure 6. Global Vaccine for Influenza Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccine for Influenza Market Size by Country (M USD)
Figure 11. Vaccine for Influenza Sales Share by Manufacturers in 2023
Figure 12. Global Vaccine for Influenza Revenue Share by Manufacturers in 2023
Figure 13. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Vaccine for Influenza Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Vaccine for Influenza Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Vaccine for Influenza Market Share by Type
Figure 18. Sales Market Share of Vaccine for Influenza by Type (2019-2024)
Figure 19. Sales Market Share of Vaccine for Influenza by Type in 2023
Figure 20. Market Size Share of Vaccine for Influenza by Type (2019-2024)
Figure 21. Market Size Market Share of Vaccine for Influenza by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Vaccine for Influenza Market Share by Application
Figure 24. Global Vaccine for Influenza Sales Market Share by Application (2019-2024)
Figure 25. Global Vaccine for Influenza Sales Market Share by Application in 2023
Figure 26. Global Vaccine for Influenza Market Share by Application (2019-2024)
Figure 27. Global Vaccine for Influenza Market Share by Application in 2023
Figure 28. Global Vaccine for Influenza Sales Growth Rate by Application (2019-2024)
Figure 29. Global Vaccine for Influenza Sales Market Share by Region (2019-2024)
Figure 30. North America Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Vaccine for Influenza Sales Market Share by Country in 2023
Figure 32. U.S. Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Vaccine for Influenza Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Vaccine for Influenza Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Vaccine for Influenza Sales Market Share by Country in 2023
Figure 37. Germany Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Vaccine for Influenza Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Vaccine for Influenza Sales Market Share by Region in 2023
Figure 44. China Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Vaccine for Influenza Sales and Growth Rate (Kilotons)
Figure 50. South America Vaccine for Influenza Sales Market Share by Country in 2023
Figure 51. Brazil Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Vaccine for Influenza Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Vaccine for Influenza Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Vaccine for Influenza Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Vaccine for Influenza Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Vaccine for Influenza Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Vaccine for Influenza Market Share Forecast by Type (2025-2030)
Figure 65. Global Vaccine for Influenza Sales Forecast by Application (2025-2030)
Figure 66. Global Vaccine for Influenza Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Vaccine for Influenza
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccine for Influenza Market Size (M USD), 2019-2030
Figure 5. Global Vaccine for Influenza Market Size (M USD) (2019-2030)
Figure 6. Global Vaccine for Influenza Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccine for Influenza Market Size by Country (M USD)
Figure 11. Vaccine for Influenza Sales Share by Manufacturers in 2023
Figure 12. Global Vaccine for Influenza Revenue Share by Manufacturers in 2023
Figure 13. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Vaccine for Influenza Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Vaccine for Influenza Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Vaccine for Influenza Market Share by Type
Figure 18. Sales Market Share of Vaccine for Influenza by Type (2019-2024)
Figure 19. Sales Market Share of Vaccine for Influenza by Type in 2023
Figure 20. Market Size Share of Vaccine for Influenza by Type (2019-2024)
Figure 21. Market Size Market Share of Vaccine for Influenza by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Vaccine for Influenza Market Share by Application
Figure 24. Global Vaccine for Influenza Sales Market Share by Application (2019-2024)
Figure 25. Global Vaccine for Influenza Sales Market Share by Application in 2023
Figure 26. Global Vaccine for Influenza Market Share by Application (2019-2024)
Figure 27. Global Vaccine for Influenza Market Share by Application in 2023
Figure 28. Global Vaccine for Influenza Sales Growth Rate by Application (2019-2024)
Figure 29. Global Vaccine for Influenza Sales Market Share by Region (2019-2024)
Figure 30. North America Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Vaccine for Influenza Sales Market Share by Country in 2023
Figure 32. U.S. Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Vaccine for Influenza Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Vaccine for Influenza Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Vaccine for Influenza Sales Market Share by Country in 2023
Figure 37. Germany Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Vaccine for Influenza Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Vaccine for Influenza Sales Market Share by Region in 2023
Figure 44. China Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Vaccine for Influenza Sales and Growth Rate (Kilotons)
Figure 50. South America Vaccine for Influenza Sales Market Share by Country in 2023
Figure 51. Brazil Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Vaccine for Influenza Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Vaccine for Influenza Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Vaccine for Influenza Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Vaccine for Influenza Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Vaccine for Influenza Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Vaccine for Influenza Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Vaccine for Influenza Market Share Forecast by Type (2025-2030)
Figure 65. Global Vaccine for Influenza Sales Forecast by Application (2025-2030)
Figure 66. Global Vaccine for Influenza Market Share Forecast by Application (2025-2030)
